Our advisory board reflects a group of diverse individuals with breadth and depth of experience across the DMD field and the broader biotech sphere. Ranging from dystrophin protein experts to rare-disease biotech CEO's, our combination of advisors provides us with a unique insight into starting a company and making it succeed.
H. Lee Sweeney, PhD
Professor of Neurology, Eminent Scholar, Director of Myology Institute, UFL
Internationally recognized muscle physiologist for ground-breaking research on muscular dystrophy